• Immune Biomarkers May Help Guide Psychedelic Treatments for Cancer-Related Depression

    Aug 21 | Diagnostics World | Researchers at The University of Texas MD Anderson Cancer Center are investigating whether immune-system biomarkers could help identify cancer patients most likely to benefit from rapid-acting psychedelic treatments for depression. Researchers examined whether these rapid-acting antidepressants share biological pathways that could serve as biomarkers for future treatment strategies. More

  • New Long-Read Sequencing Tool Targets Difficult-to-Detect Cancer Mutations

    Aug 20 | Diagnostics World | Analyzing genetic changes in cancer cells provides insight into how tumors develop and help with developing treatment through precision oncology. Long-read sequencing can help, but there is still a higher error rate compared to short-read sequencing. Researchers at The University of Hong Kong addressed this gap with ClairS, a tool designed to identify small cancer-related genetic mutations. More

  • Home Test for Diabetes Risk has a Leg Up on Standard Methods

    Aug 18 | Diagnostics World | The worried well the world over now have readily accessible and easy to self-administer home tests for assessing their risk for diabetes and chronic kidney disease, thanks to the computational skills of a pair of researchers at DTU Sustain, based at the Technical University of Denmark. The new online tools focus on a small number of parameters identified by artificial intelligence (AI) as being the most important among hundreds of possibilities in the long-running National Health and Nutrition Examination Survey (NHANES) in the U.S. More

  • Mapping the Brain Across Timescales May Improve Neurological Diagnostics

    Aug 13 | Diagnostics World | Researchers have uncovered evidence that the brain coordinates information across multiple timescales without requiring those processes to be synchronized moment to moment, a finding that could eventually inform new approaches to neurological and psychiatric diagnostics. More

  • Human Longevity Launches $600 Whole Genome

    Aug 11 | Diagnostics World | Human Longevity last week announced the availability of Genomics for All, a clinical-grade whole genome sequencing product priced at $599. The offering sequences all 6.4 billion base pairs of an individual's DNA and delivers AI-interpreted results through the HLI app, with no clinic visit required. More

  • New CEO for PacBio, Updated Chemistry for Vega System

    Aug 07 | Diagnostics World | PacBio made several announcements this week: Mark Van Oene is the new President and CEO for the company and new chemistry and software are available for its Vega systems. Both changes aim to position the company for wider platform adoption across labs and research areas. More

  • Biomarkers Bring Long-Awaited Hope to Those at Genetic Risk for ALS

    Aug 05 | Diagnostics World | Blood-based biomarkers predicting when symptoms of amyotrophic lateral sclerosis (ALS) will emerge are expected to catapult the medical research community forward in the quest to prevent the fatal neurodegenerative disorder. Researchers from the University of Miami Miller School of Medicine have been spearheading the Pre-Symptomatic Familial ALS (Pre-fALS) study collecting longitudinal data and biological samples from people at elevated genetic risk for ALS since the project’s 2007 inception. More

  • Samsung, UCSF Study Smartwatch Data as Potential Biomarkers of Cognitive Health

    Aug 04 | Diagnostics World | Smartwatches could one day do more than track steps, sleep, and heart rate. Researchers at the University of California San Francisco (UCSF) are working with Samsung to determine whether physiological data collected passively by a smartwatch can help identify early changes in cognitive function. More

  • Follow the Money: Novel NeuroAI Model, Autoimmune, Inflammatory Disease Treatment, Drug Discovery

    Jul 29 | Diagnostics World | Fresenius expands its access to innovation networks through its own corporate venture capital fund over the next five years; Transcripta Bio's closed-loop discovery engine is designed to use transcriptomic signature matching to identify drugs whose molecular signatures are the inverse of patient-derived disease signatures; and more. More

  • Seegene Multiplex PCR Test, QIAGEN Launches New Panel, At-Home HIV Tests

    Jul 28 | Diagnostics World | Myriad Genetics announces the full commercial launch of FirstGene Multiple Prenatal Screen; Amprion reaches an agreement with Decathlon Capital Partners for a significant growth-funding investment; and more. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more